Marina Botto

20.1k citations

194 papers · 14.9k · 3 hit papers · h-index 67

Impact in

Immunology top 0.05%
- Complement system in diseases
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Phagocytosis and Immune Regulation
- Immunotherapy and Immune Responses
Nephrology top 0.2%
- Renal Diseases and Glomerulopathies

Papers in

Immunology 142
- Complement system in diseases 98
- T-cell and B-cell Immunology 31
- Immune Cell Function and Interaction 22
- Phagocytosis and Immune Regulation 19
Hematology 41
- Platelet Disorders and Treatments 18

Co-authors: Mark Walport (70 shared papers)H. Terence Cook (38 shared papers)Matthew C. Pickering (36 shared papers)Philip R. Taylor (20 shared papers)Kevin Davies (8 shared papers)Anne E. Bygrave (12 shared papers)Anthony P. Manderson (8 shared papers)Liliane Fossati‐Jimack (24 shared papers)
Journals: The Journal of Immunology (21 papers)Molecular Immunology (15 papers)European Journal of Immunology (11 papers)The Journal of Experimental Medicine (8 papers)Infection and Immunity (7 papers)
Partner nations: United Kingdom United States Italy

In The Last Decade

Marina Botto

193 papers receiving 14.7k citations

Marina Botto's Hit Papers

align trajectories log scale

Dectin-1 is required for β-glucan recognition and control of fungal infection 2006 · 920 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2006 Nature Immunology
2002 Nature
2000 The Journal of Experimental Medicine

Peers

Countries citing papers authored by Marina Botto

Since Specialization

Citations

This map shows the geographic impact of Marina Botto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Botto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Botto more than expected).

Fields of papers citing papers by Marina Botto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Botto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Botto. The network helps show where Marina Botto may publish in the future.

Co-authors

The 25 scholars most cited alongside Marina Botto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marina Botto Line = papers co-authored together Marina Botto links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Dectin-1 is required for β-glucan recognition and control of fungal infection Nature Immunology ·Philip R. Taylor, S. Vicky Tsoni, Janet A. Willment, Kevin M. Dennehy, Marcela Rosas, Helen Findon, Ken Haynes, Chad Steele, Marina Botto, Siamon Gordon, Gordon D. Brown Hit paper breakdown →	2006	920
2	A Hierarchical Role for Classical Pathway Complement Proteins in the Clearance of Apoptotic Cells in Vivo The Journal of Experimental Medicine ·Philip R. Taylor, Anna Carugati, Valerie A. Fadok, H. Terence Cook, Mark Andrews, Michael C. Carroll, John Savill, Peter M. Henson, Marina Botto, Mark Walport Hit paper breakdown →	2000	579
3	Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response Nature ·Cecília Garlanda, Emilio Hirsch, Silvia Bozza, Antonietta Salustri, Marika De Acetis, Rachele Nota, Alessia Maccagno, Federica Riva, Barbara Bottazzi, Giuseppe Peri, Andrea Doni, Luca Vago, Marina Botto, Rita De Santis, Paolo Carminati, Gregorio Siracusa, Fiorella Altruda, Annunciata Vecchi, Luigina Romani, Alberto Mantovani Hit paper breakdown →	2002	538
4	Role of Surfactant Proteins A, D, and C1q in the Clearance of Apoptotic Cells In Vivo and In Vitro: Calreticulin and CD91 as a Common Collectin Receptor Complex The Journal of Immunology ·R. William Vandivier, Carol Anne Ogden, Valerie A. Fadok, Peter R. Hoffmann, Kevin K. Brown, Marina Botto, Mark Walport, James H. Fisher, Peter M. Henson, Kelly E. Greene	2002	421
5	Complement Activation Determines the Therapeutic Activity of Rituximab In Vivo The Journal of Immunology ·Nicola Di Gaetano, Elena Cittera, Rachele Nota, Annunciata Vecchi, Valeria Grieco, Eugenio Scanziani, Marina Botto, Martino Introna, Josée Golay	2003	417
6	Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H Nature Genetics ·Matthew C. Pickering, H. Terence Cook, Joanna Warren, Anne E. Bygrave, Jill Moss, Mark Walport, Marina Botto	2002	402
7	Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity Nature Medicine ·Maria C. M. Bickerstaff, Marina Botto, W. L. Hutchinson, J. Herbert, Glenys A. Tennent, A Bybee, Daniel A. Mitchell, H. Terence Cook, P.J.G. Butler, Mark Walport, Mark B. Pepys	1999	396
8	Systemic Lupus Erythematosus, Complement Deficiency, and Apoptosis Advances in immunology ·Matthew C. Pickering, Marina Botto, Philip R. Taylor, P. J. Lachmann, Mark Walport	2001	390
9	The Role of Complement in the Development of Systemic Lupus Erythematosus Annual Review of Immunology ·Anthony P. Manderson, Marina Botto, Mark Walport	2004	383
10	C1q and Systemic Lupus Erythematosus Immunobiology ·Mark Walport, Kevin Davies, Marina Botto	1998	288
11	The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice Proceedings of the National Academy of Sciences ·Jeremy Brown, Tracy Hussell, Sarah M. Gilliland, David W. Holden, James C. Paton, Michael R. Ehrenstein, Mark Walport, Marina Botto	2002	281
12	Absence of C1q Leads to Less Neuropathology in Transgenic Mouse Models of Alzheimer's Disease Journal of Neuroscience ·María Isabel Fonseca, Jun Zhou, Marina Botto, Andrea J. Tenner	2004	272
13	Antibodies to human serum amyloid P component eliminate visceral amyloid deposits Nature ·Karl Bodin, Stéphan Ellmerich, Melvyn Kahan, Glenys A. Tennent, Andrzej Loesch, Janet A. Gilbertson, Winston L. Hutchinson, P. Patrizia Mangione, J. Ruth Gallimore, David J. Millar, Shane Minogue, Amar P. Dhillon, Graham W. Taylor, A.R. Bradwell, Aviva Petrie, Julian D. Gillmore, Vittorio Bellotti, Marina Botto, Philip N. Hawkins, Mark B. Pepys	2010	246
14	C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation Nature Communications ·Roberta Bulla, Claudio Tripodo, Damiano Rami, Guang Sheng Ling, Chiara Agostinis, Carla Guarnotta, Sonia Zorzet, Paolo Durigutto, Marina Botto, Francesco Tedesco	2016	227
15	Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains The Journal of Experimental Medicine ·Matthew C. Pickering, Elena Goicoechea de Jorge, Rubén Martínez-Barricarte, Sergio Recalde, Alfredo García‐Layana, Kirsten L. Rose, Jill Moss, Mark Walport, H. Terence Cook, Santiago Rodrı́guez de Córdoba, Marina Botto	2007	222
16	C1q, Autoimmunity and Apoptosis Immunobiology ·Marina Botto	2002	220
17	Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells Immunity ·Timotheus Y.F. Halim, Batika M.J. Rana, Jennifer A. Walker, Bernhard Kerscher, Martin Knolle, Helen E. Jolin, Eva Serrão, Liora Haim-Vilmovsky, Sarah A. Teichmann, Hans‐Reimer Rodewald, Marina Botto, Timothy J. Vyse, Padraic G. Fallon, Zhi Li, David R. Withers, Andrew N. J. McKenzie	2018	207
18	Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene Nature Medicine ·Marina Botto, Philip N. Hawkins, Maria C. M. Bickerstaff, Jeff Herbert, Anne E. Bygrave, Alan J. A. McBride, Winston L. Hutchinson, Glenys A. Tennent, Mark Walport, Mark B. Pepys	1997	201
19	Autophagy is activated in systemic lupus erythematosus and required for plasmablast development Annals of the Rheumatic Diseases ·Alexander J. Clarke, Ursula Ellinghaus, Andrea Cortini, Amanda J. Stranks, Anna Katharina Simon, Marina Botto, Timothy J. Vyse	2014	198
20	Immunoglobulin M Is Required for Protection Against Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice Circulation ·Myles Lewis, Talat H. Malik, Michael R. Ehrenstein, Joseph J. Boyle, Marina Botto, Dorian O. Haskard	2009	191

About Marina Botto

Marina Botto is a scholar working on Immunology, Hematology, Nephrology, Rheumatology and Molecular Biology, having authored 194 papers that have together received 14.9k indexed citations. Recurring topics across this work include Complement system in diseases (98 papers), T-cell and B-cell Immunology (31 papers), Renal Diseases and Glomerulopathies (25 papers), Systemic Lupus Erythematosus Research (25 papers), Immune Cell Function and Interaction (22 papers), Monoclonal and Polyclonal Antibodies Research (19 papers), Phagocytosis and Immune Regulation (19 papers) and Platelet Disorders and Treatments (18 papers). The work is most often cited by research in Immunology (9.5k citations), Nephrology (1.5k citations), Rheumatology (1.9k citations), Hematology (1.4k citations) and Microbiology (518 citations). Marina Botto has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Mark Walport, H. Terence Cook, Matthew C. Pickering, Philip R. Taylor, Kevin Davies, Anne E. Bygrave, Anthony P. Manderson, Liliane Fossati‐Jimack, Joanna Warren and Mark B. Pepys. Their work appears in journals such as The Journal of Immunology, Molecular Immunology, European Journal of Immunology, The Journal of Experimental Medicine and Infection and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Marina Botto

Impact in

Papers in i

In The Last Decade

Marina Botto

Marina Botto's Hit Papers

Peers

Countries citing papers authored by Marina Botto

Fields of papers citing papers by Marina Botto

All Works

About Marina Botto

Explore authors with similar magnitude of impact

Papers in